L1CAM expression in colorectal cancer identifies a high-risk group of patients with dismal prognosis already in early-stage disease

Authors

Athanasios Tampakis Clarunis University Center for Gastrointestinal and Liver Disorders, University Hospital of Basel, Basel, Switzerland; ;2nd Department of Propedeutic Surgery, Athens University Medical School, Laiko General Hospital, Athens, Greece
Ekaterini Christina Tampaki 2nd Department of Propedeutic Surgery, Athens University Medical School, Laiko General Hospital, Athens, Greece
Afroditi Nonni 1st Department of Pathology, School of Medicine, National University of Athens, Athens, Greece
Gerasimos Tsourouflis 2nd Department of Propedeutic Surgery, Athens University Medical School, Laiko General Hospital, Athens, Greece
Alberto Posabella Clarunis University Center for Gastrointestinal and Liver Disorders, University Hospital of Basel, Basel, Switzerland
Efstratios Patsouris 1st Department of Pathology, School of Medicine, National University of Athens, Athens, Greece
Konstantinos Kontzoglou 2nd Department of Propedeutic Surgery, Athens University Medical School, Laiko General Hospital, Athens, Greece
Markus von Flüe Clarunis University Center for Gastrointestinal and Liver Disorders, University Hospital of Basel, Basel, Switzerland
Nikolaos Nikiteas 2nd Department of Propedeutic Surgery, Athens University Medical School, Laiko General Hospital, Athens, Greece
Gregory Kouraklis 2nd Department of Propedeutic Surgery, Athens University Medical School, Laiko General Hospital, Athens, Greece

Diagnosis, treatment, neuroendocrine tumour, neuroendocrine carcinoma

No abstract available

Download data is not yet available.